Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$240,342
-$39,924 QoQ
Shares Held
9,981
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,307
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Silvant Capital Management LLC holds $144,195,613 across 8 Drug Manufacturers - General names. PFE ranks #7 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
115,077 | $138,026,817 | |
| 2 | MRK |
Merck & Co., Inc.
|
25,811 | $3,316,713 | |
| 3 | ABBV |
AbbVie Inc.
|
4,037 | $1,015,870 | |
| 4 | JNJ |
Johnson & Johnson
|
2,471 | $627,559 | |
| 5 | AMGN |
Amgen Inc
|
1,245 | $450,839 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,887 | $339,208 | |
| 7 | PFE |
Pfizer Inc
This page
|
9,981 | $240,342 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,411 | $178,265 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $240,342 | 9,981 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $280,266 | 9,981 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $248,526 | 9,981 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $254,315 | 9,981 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $241,939 | 9,981 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $252,918 | 9,981 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $264,795 | 9,981 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $288,850 | 9,981 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $279,268 | 9,981 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $276,972 | 9,981 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $287,352 | 9,981 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $2,935,975 | 88,513 | Shares | Other | 2023-10-24 | |
| 2023-06-30 | $3,246,656 | 88,513 | Shares | Other | 2023-07-25 | |
| 2023-03-31 | $4,188,364 | 102,656 | Shares | Other | 2023-04-26 | |
| 2022-12-31 | $5,260,092 | 102,656 | Shares | Other | 2023-01-23 | |
| 2022-09-30 | $4,502,291 | 102,886 | Shares | Other | 2022-11-09 | |
| 2022-06-30 | $5,441,447 | 103,785 | Shares | Other | 2022-08-03 | |
| 2022-03-31 | $5,445,996 | 105,196 | Shares | Other | 2022-05-05 | |
| 2021-12-31 | $6,362,460 | 107,747 | Shares | Other | 2022-02-07 | |
| 2021-09-30 | $3,413,144 | 79,357 | Shares | Other | 2021-11-08 | |
| 2021-06-30 | $3,394,505 | 86,683 | Shares | Other | 2021-08-03 | |
| 2021-03-31 | $3,223,599 | 88,976 | Shares | Other | 2021-05-11 | |
| 2020-12-31 | $3,275,205 | 88,976 | Shares | Other | 2021-02-05 | |
| 2020-09-30 | $3,283,655 | 89,473 | Shares | Other | 2020-11-09 | |
| 2020-06-30 | $2,968,933 | 90,793 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $2,963,479 | 90,793 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||